181 related articles for article (PubMed ID: 33957804)
1. Metabolomic profiling of anaerobic and aerobic energy metabolic pathways in chronic obstructive pulmonary disease.
Xue M; Zeng Y; Lin R; Qu HQ; Zhang T; Zhang XD; Liang Y; Zhen Y; Chen H; Huang Z; Hu H; Zheng P; Hakonarson H; Zhou L; Sun B
Exp Biol Med (Maywood); 2021 Jul; 246(14):1586-1596. PubMed ID: 33957804
[TBL] [Abstract][Full Text] [Related]
2. An Integrative Transcriptomic and Metabolomic Study Revealed That Melatonin Plays a Protective Role in Chronic Lung Inflammation by Reducing Necroptosis.
Mao K; Luo P; Geng W; Xu J; Liao Y; Zhong H; Ma P; Tan Q; Xia H; Duan L; Song S; Long D; Liu Y; Yang T; Wu Y; Jin Y
Front Immunol; 2021; 12():668002. PubMed ID: 34017341
[TBL] [Abstract][Full Text] [Related]
3. Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease.
Diao W; Labaki WW; Han MK; Yeomans L; Sun Y; Smiley Z; Kim JH; McHugh C; Xiang P; Shen N; Sun X; Guo C; Lu M; Standiford TJ; He B; Stringer KA
Int J Chron Obstruct Pulmon Dis; 2019; 14():2015-2025. PubMed ID: 31564849
[TBL] [Abstract][Full Text] [Related]
4. Integrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations.
Li J; Zhao P; Yang L; Li Y; Tian Y; Li S; Bai Y
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28450497
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases.
Adamko DJ; Nair P; Mayers I; Tsuyuki RT; Regush S; Rowe BH
J Allergy Clin Immunol; 2015 Sep; 136(3):571-580.e3. PubMed ID: 26152317
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic Profiling Differences among Asthma, COPD, and Healthy Subjects: A LC-MS-based Metabolomic Analysis.
Liang Y; Gai XY; Chang C; Zhang X; Wang J; Li TT
Biomed Environ Sci; 2019 Sep; 32(9):659-672. PubMed ID: 31635682
[TBL] [Abstract][Full Text] [Related]
7. Phenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical Characteristics.
Kilk K; Aug A; Ottas A; Soomets U; Altraja S; Altraja A
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495451
[TBL] [Abstract][Full Text] [Related]
8. Serum metabolomics analysis of patients with chronic obstructive pulmonary disease and 'frequent exacerbator' phenotype.
Ding HZ; Wang H; Wu D; Zhou FC; Zhu J; Tong JB; Gao YT; Li ZG
Mol Med Rep; 2024 Aug; 30(2):. PubMed ID: 38873983
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic Analysis of Respiratory Epithelial Lining Fluid in Patients with Chronic Obstructive Pulmonary Disease-A Systematic Review.
Pulik K; Mycroft K; Korczyński P; Ciechanowicz AK; Górska K
Cells; 2023 Mar; 12(6):. PubMed ID: 36980173
[TBL] [Abstract][Full Text] [Related]
10. Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease.
Zhao P; Li J; Yang L; Li Y; Tian Y; Li S
Mol Med Rep; 2018 Apr; 17(4):5247-5257. PubMed ID: 29393428
[TBL] [Abstract][Full Text] [Related]
11. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
[TBL] [Abstract][Full Text] [Related]
12. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.
Madapoosi SS; Cruickshank-Quinn C; Opron K; Erb-Downward JR; Begley LA; Li G; Barjaktarevic I; Barr RG; Comellas AP; Couper DJ; Cooper CB; Freeman CM; Han MK; Kaner RJ; Labaki W; Martinez FJ; Ortega VE; Peters SP; Paine R; Woodruff P; Curtis JL; Huffnagle GB; Stringer KA; Bowler RP; Esther CR; Reisdorph N; Huang YJ;
Am J Respir Crit Care Med; 2022 Aug; 206(4):427-439. PubMed ID: 35536732
[No Abstract] [Full Text] [Related]
13. Metabolic profiling of chronic obstructive pulmonary disease model rats and the interventional effects of HuaTanJiangQi decoction using UHPLC-Q-TOF/MS
Fang W; Li C; Wu Q; Yao Z; Wu J; Huang P; Wang D; Li Z
J Pharm Biomed Anal; 2020 Feb; 180():113078. PubMed ID: 31911286
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics study on model rats of chronic obstructive pulmonary disease treated with Bu‑Fei Jian‑Pi.
Li J; Yang L; Li Y; Tian Y; Li S; Jiang S; Wang Y; Li X
Mol Med Rep; 2015 Feb; 11(2):1324-33. PubMed ID: 25370181
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD.
Ghosh N; Choudhury P; Subramani E; Saha D; Sengupta S; Joshi M; Banerjee R; Roychowdhury S; Bhattacharyya P; Chaudhury K
Metabolomics; 2019 Jun; 15(6):87. PubMed ID: 31165288
[TBL] [Abstract][Full Text] [Related]
16. Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease.
Zhou J; Li Q; Liu C; Pang R; Yin Y
Int J Chron Obstruct Pulmon Dis; 2020; 15():553-565. PubMed ID: 32210549
[TBL] [Abstract][Full Text] [Related]
17. Muscle metabolomics analysis reveals potential biomarkers of exercise‑dependent improvement of the diaphragm function in chronic obstructive pulmonary disease.
Li J; Lu Y; Li N; Li P; Su J; Wang Z; Wang T; Yang Z; Yang Y; Chen H; Xiao L; Duan H; Wu W; Liu X
Int J Mol Med; 2020 Jun; 45(6):1644-1660. PubMed ID: 32186768
[TBL] [Abstract][Full Text] [Related]
18. The Correlation of Sit-to-Stand Tests with COPD Assessment Test and GOLD Staging Classification.
Kakavas S; Papanikolaou A; Kompogiorgas S; Stavrinoudakis E; Karayiannis D; Balis E
COPD; 2020 Dec; 17(6):655-661. PubMed ID: 33023324
[TBL] [Abstract][Full Text] [Related]
19. [The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].
Wan P; Zhong XN; He ZY; Zhang JQ; Liu GN; Lao QF
Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):841-5. PubMed ID: 20079227
[TBL] [Abstract][Full Text] [Related]
20. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
Mittal R; Chhabra SK
COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
